Dr. Balasubramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2335 E Kashian Ln
Ste 260
Fresno, CA 93701Phone+1 559-256-5130Fax+1 559-485-4504
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2001 - 2003
- Stanley Medical College SMCClass of 1993
Certifications & Licensure
- CA State Medical License 2006 - 2025
- WI State Medical License 2002 - 2007
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 47 citationsCombination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trialR. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda
American Journal of Respiratory and Critical Care Medicine. 2020-03-15 - 7 citationsParticipation in pulmonary hypertension support group improves patient-reported health quality outcomes: a patient and caregiver survey:Paresh C. Giri, Gizelle J Stevens, Jeanette Merrill-Henry, Udochukwu Oyoyo, Vijay Balasubramanian
Pulmonary Circulation. 2021-05-17 - 24 citationsAggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?Carmine Dario Vizza, Irene M Lang, Roberto Badagliacca, Raymond L Benza, Stephan Rosenkranz
American Journal of Respiratory and Critical Care Medicine. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: